Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics Inc (DE:F6T)
:F6T
F6T Analyst Ratings
Moderate Buy
4 Buy
9 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
F6T Stock 12 Month Forecast
Average Price Target
€4.60
▲(400.08% Upside)
| Highest Price Target€10.72 | Average Price Target€4.60 | Lowest Price Target€1.79 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Fate Therapeutics
Which Analyst Should I Follow If I Want to Buy DE:F6T and Sell After:
1 Month
xxx
Success Rate
10/28 ratings generated profit
Average Return
-4.19%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 35.71% of your transactions generating a profit, with an average return of -4.19% per trade.
3 Months
xxx
Success Rate
10/28 ratings generated profit
Average Return
-2.16%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of -2.16% per trade.
1 Year
Success Rate
5/28 ratings generated profit
Average Return
-20.41%
reiterated a buy rating 2 months ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 17.86% of your transactions generating a profit, with an average return of -20.41% per trade.
2 Years
xxx
Success Rate
2/28 ratings generated profit
Average Return
-53.07%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.14% of your transactions generating a profit, with an average return of -53.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
F6T Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
6
7
6
4
6
Buy
3
3
2
0
0
Hold
21
23
14
2
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
33
22
6
15
Each month's total comprises the sum of three months' worth of ratings.
F6T Financial Forecast
F6T Stock Forecast FAQ
What is DE:F6T’s average 12-month price target, according to analysts?
Based on analyst ratings, Fate Therapeutics Inc’s 12-month average price target is 4.60.
What is DE:F6T’s upside potential, based on the analysts’ average price target?
Fate Therapeutics Inc has 400.08% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fate Therapeutics Inc a Buy, Sell or Hold?
Fate Therapeutics Inc has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 9 hold ratings and 0 sell ratings.
What is Fate Therapeutics Inc’s share price target?
The average share price target for Fate Therapeutics Inc is 4.60. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €10.72 ,and the lowest forecast is €1.79. The average share price target represents 400.08% Increase from the current price of €0.92.
The highest analyst share price target is €10.72 ,and the lowest forecast is €1.79. The average share price target represents 400.08% Increase from the current price of €0.92.
What do analysts say about Fate Therapeutics Inc?
Fate Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Fate Therapeutics Inc?
To buy shares of DE:F6T, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.